Table 2 Association between circFNDC3B expression levels and clinicopathological characteristics of CRC patients.
Clinical parameters | Cases (n) | circFNDC3B expression | P-value (*p < 0.05) | |
|---|---|---|---|---|
High (n) | Low (n) | |||
Gender | Â | Â | Â | 0.592 |
 Male | 35 | 19 | 16 | – |
 Female | 23 | 10 | 13 | – |
Age | Â | Â | Â | 0.792 |
 <60 | 26 | 12 | 14 | – |
 ≥60 | 32 | 17 | 15 | – |
Tumor size (cm) | Â | Â | Â | 0.065 |
 <5 | 28 | 18 | 10 | – |
 ≥5 | 30 | 11 | 19 | – |
Location | Â | Â | Â | 0.292 |
 Rectum | 27 | 16 | 11 | – |
 Colon | 31 | 13 | 18 | – |
TNM stage | Â | Â | Â | 0.033 |
 I–II | 25 | 17 | 8 | – |
 III–IV | 33 | 12 | 21 | – |
Histological type | Â | Â | Â | 0.182 |
 Differentiated | 24 | 15 | 9 | – |
 Undifferentiated | 34 | 14 | 20 | – |
Lymph node metastasis | Â | Â | Â | 0.017 |
 Yes | 26 | 8 | 18 | – |
 No | 32 | 21 | 11 | – |